2m 2m 2m 2m 2m 2m 2m
Exelixis (EXEL)
NASDAQ
$51.27-$0.08 (-0.15%)
Price as of Jun 23, 2026 10:06 AM EDT- $12.9BMarket Cap
- 18.40%1-Year Change
- BiotechnologyIndustry
Exelixis (EXEL)
$51.27-$0.08 (-0.15%)
Annual
Quarterly
01/02/2026 | 01/03/2025 | 12/29/2023 | 12/30/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 2.1B -2.12% | 2.2B +18.49% | 1.8B +13.60% | 1.6B +12.27% | |
Cost of Revenue | 83.7M +9.82% | 76.2M +5.06% | 72.5M +25.28% | 57.9M +9.52% | |
Gross Profit | 2.0B -2.55% | 2.1B +19.05% | 1.8B +13.17% | 1.6B +12.38% | |
Sales and Marketing Expense | 518.7M +5.40% | 492.1M -9.32% | 542.7M +18.02% | 459.9M +14.47% | |
Research and Development Expense | -825.0M -9.38% | -910.4M -12.80% | -1.0B +17.07% | -891.8M +28.56% | |
Depreciation and Amortization Expense | 29.1M +0.87% | 28.8M +12.00% | 25.7M +23.20% | 20.9M +53.15% | |
Total Operating Expenses | 1.4B -7.43% | 1.6B -5.74% | 1.7B +17.72% | 1.4B +22.75% | |
Operating Profit | 872.2M +44.26% | 604.6M +253.82% | 170.9M -15.19% | 201.5M -29.71% | |
Interest Income | 69.2M -10.29% | 77.2M -10.85% | 86.5M +161.74% | 33.1M +330.98% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 69.2M -10.29% | 77.2M -10.85% | 86.5M +161.74% | 33.1M +330.98% | |
Total Nonoperating Income and Expense | -198,000 +48.87% | -133,000 -243.01% | 93,000 +147.21% | -197,000 +7.07% | |
Income before Taxes | 941.2M +38.08% | 681.6M +164.69% | 257.5M +9.89% | 234.4M -20.33% | |
Income Taxes | 158.6M -1.08% | 160.4M +222.32% | 49.8M -4.44% | 52.1M -17.47% | |
Extraordinary Items | 0 -100.00% | 64.4M N/A | N/A N/A | N/A N/A | |
Net Income | 782.6M +50.13% | 521.3M +150.89% | 207.8M +13.98% | 182.3M -21.11% | |
Net Income from Continuing Operations Applicable to Common | 782.6M +50.13% | 521.3M +150.89% | 207.8M +13.98% | 182.3M -21.11% | |
Basic EPS and Net Income | 2.88 +60.00% | 1.80 +176.92% | 0.65 +14.04% | 0.57 -21.92% | |
Diluted EPS and Net Income | 2.78 +57.95% | 1.76 +170.77% | 0.65 +16.07% | 0.56 -22.22% | |
Basic Weighted Average Shares | 271.6M -6.37% | 290.0M -8.84% | 318.2M -1.05% | 321.5M +2.11% | |
Diluted Weighted Average Shares | 281.9M -4.82% | 296.1M -7.88% | 321.5M -0.95% | 324.6M +0.68% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 482.5M +121.96% | 217.4M -17.35% | 263.0M -47.53% | 501.2M -22.56% | |
Short-Term Investments | 576.6M -35.50% | 893.9M +22.07% | 732.3M -9.29% | 807.3M -1.54% | |
Cash and Cash Equivalents and Short-Term Investments | 1.1B -4.70% | 1.1B +11.65% | 995.3M -23.93% | 1.3B -10.81% | |
Total Current Assets | 1.4B -1.66% | 1.5B +11.35% | 1.3B -18.58% | 1.6B -11.77% | |
Accumulated Depreciation | 132.2M +31.27% | 100.7M +25.30% | 80.4M +32.06% | 60.9M +49.08% | |
Property and Plant and Equipment and Net | 99.0M -17.11% | 119.4M -7.26% | 128.7M +16.37% | 110.6M +6.34% | |
Total Long-Term Assets | 702.6M -7.15% | 756.7M +487.80% | 128.7M +16.37% | 110.6M -15.56% | |
Total Assets | 2.8B -3.50% | 2.9B +0.18% | 2.9B -4.20% | 3.1B +17.40% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 405.6M +0.46% | 403.8M +2.41% | 394.3M +21.56% | 324.4M -3.92% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 104.4M -4.11% | 108.9M +15.57% | 94.2M +52.09% | 62.0M +672.17% | |
Total Liabilities | 683.1M -2.90% | 703.5M +3.69% | 678.4M +16.36% | 583.1M +43.74% | |
Retained Earnings | -76.8M -22.12% | -98.6M -43.09% | -173.4M +406.50% | -34.2M -84.19% | |
Total Stockholders Equity | 2.2B -3.69% | 2.2B -0.87% | 2.3B -9.02% | 2.5B +12.57% | |
Total Shares Outstanding | 262.5M -6.83% | 281.7M -6.96% | 302.8M -6.53% | 324.0M +1.60% | |
Cash Flow | |||||
Cash from Operating Activities | 884.3M +26.33% | 700.0M +110.00% | 333.3M -8.08% | 362.6M -9.53% | |
Capital Expenditures | 8.4M -70.36% | 28.4M -29.74% | 40.5M +46.07% | 27.7M -56.86% | |
Cash from Investing Activities | 350.4M +400.08% | -116.8M +333.25% | -27.0M -94.86% | -524.4M +1,122.87% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -969.6M +54.20% | -628.8M +15.16% | -546.1M -93,282.94% | 586,000 +103.96% | |
Financials Ratio | |||||
Gross Margin | 96.06% N/A | N/A N/A | 96.04% -0.38% | 96.41% +0.09% | |
Operating Margin | 41.09% N/A | N/A N/A | 9.34% -25.34% | 12.51% -37.40% | |
Return on Assets | 27.02% N/A | N/A N/A | 6.91% +7.80% | 6.41% -37.56% | |
Return on Equity | 35.53% N/A | N/A N/A | 8.74% +12.70% | 7.76% -34.58% | |
Revenue Growth | -2.12% N/A | N/A N/A | 13.60% +10.85% | 12.27% -74.58% | |
Current Ratio | 3.56 N/A | N/A N/A | 3.34 -33.02% | 4.99 -8.17% | |
Cash Ratio | 1.19 N/A | N/A N/A | 0.67 -56.83% | 1.55 -19.39% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow